Bottomley P A, Hardy C J, Roemer P B, Weiss R G
General Electric Corporate Research and Development Center, Schenectady, New York 12301.
NMR Biomed. 1989 Dec;2(5-6):284-9. doi: 10.1002/nbm.1940020518.
Several technological problems in in vivo localized spectroscopy of metabolism are discussed in the context of comparing data obtained by different means. Deficiencies in spectroscopy localization methods can produce spectra that are dominated by artefactual signals derived from outside of selected volumes. Such artefacts are not usually correctly accounted for by representations of the profiles of the transverse magnetization alone. Selected sensitive volumes should be defined in terms of the size of tissue contributing the major fraction of signal to an observed spectrum, which is the integrated response from the sample including any phase cancellation effects. Phase cancellation in one-dimensional localization techniques employing excitation by an RF field with uniform phase distribution and surface coil detection such as depth resolved surface coil spectroscopy, chemical shift imaging (CSI) and rotating frame zeugmatography (RFZ) can significantly alter the effective radius of the sensitive volumes depending on the sample distribution and the extent of the homogeneous region of the magnet. Also, discrete spatial sampling in RFZ and CSI can radiate signal artefacts of around 25% into adjacent elements depending on the location and distribution of signal sources. Acquisition delays between excitation and detection and partial saturation are other major sources of systematic error. Saturation factors for metabolites are not easily obtainable on localized volumes during clinical exams on an individual basis, but may be expediently obtained as larger-volume tissue-averages. Better documentation of saturation effects, acquisition delays and localized volume sizes is needed to compare and validate clinical results and performance.
在比较通过不同方法获得的数据的背景下,讨论了体内代谢局部光谱学中的几个技术问题。光谱定位方法的不足会产生由选定体积之外的伪信号主导的光谱。仅通过横向磁化分布来表示通常无法正确解释此类伪影。选定的敏感体积应以对观察到的光谱贡献主要信号部分的组织大小来定义,这是来自样品的综合响应,包括任何相位抵消效应。在采用具有均匀相位分布的射频场激发和表面线圈检测的一维定位技术中,如深度分辨表面线圈光谱、化学位移成像(CSI)和旋转框架磁共振成像(RFZ),相位抵消会根据样品分布和磁体均匀区域的范围显著改变敏感体积的有效半径。此外,根据信号源的位置和分布,RFZ和CSI中的离散空间采样会将约25%的信号伪影辐射到相邻单元中。激发与检测之间的采集延迟和部分饱和是系统误差的其他主要来源。在个体临床检查期间,不容易在局部体积上获得代谢物的饱和因子,但可以方便地作为更大体积的组织平均值来获得。需要更好地记录饱和效应、采集延迟和局部体积大小,以比较和验证临床结果及性能。